Quantum Biopharma (QNTM) Cash from Discontinued Operations (2019 - 2022)
Quantum Biopharma recorded quarterly Cash from Discontinued Operations of 504264.0 in Q1 2022, up 80.67% quarter-over-quarter from 2608536.0 in Q4 2021, and down 175.04% year-over-year from 672013.0 in Q1 2021.
Quantum Biopharma's Cash from Discontinued Operations history runs 4 years deep, the most recent figure standing at 504264.0 for Q1 2022.
- In Q1 2022, Cash from Discontinued Operations fell 175.04% year-over-year to 504264.0; the TTM figure through Mar 2022 stood at 2558318.0 (down 1725.79% YoY), while the FY2022 annual figure was 1142982.0, up 17.3% from the prior year.
- Cash from Discontinued Operations came in at 504264.0 for Q1 2022 at Quantum Biopharma, up from 2608536.0 in the prior quarter.
- In the past five years, Cash from Discontinued Operations ranged from a high of 1539547.64 in Q1 2019 to a low of 2608536.0 in Q4 2021.
- A 4-year average of 95712.48 and a median of 80935.53 in 2020 frame the typical range for Cash from Discontinued Operations.
- Across the five-year window, Cash from Discontinued Operations surged 930.31% in 2021 and slumped 175.04% in 2022, its largest moves.
- Quantum Biopharma's Cash from Discontinued Operations stood at 1539547.64 in 2019, then plunged by 106.4% to 98471.34 in 2020, then slumped by 2549.03% to 2608536.0 in 2021, then jumped by 80.67% to 504264.0 in 2022.
- According to Business Quant data, Cash from Discontinued Operations over the past three periods registered 504264.0, 2608536.0, and 314573.0 for Q1 2022, Q4 2021, and Q3 2021 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -504,264.00 |
| Mar 31, 2022 | -504,264.00 |
| Dec 31, 2021 | -2.61 Mn |
| Dec 31, 2021 | -2.61 Mn |
| Sep 30, 2021 | 314,573.00 |
| Sep 30, 2021 | 314,573.00 |
| Jun 30, 2021 | 239,909.00 |
| Jun 30, 2021 | 239,909.00 |
| Mar 31, 2021 | 672,013.00 |
| Mar 31, 2021 | 672,013.00 |
| Sep 30, 2020 | -98,471.34 |
| Sep 30, 2020 | -98,471.34 |
| Jun 30, 2020 | -335,248.05 |
| Jun 30, 2020 | -335,248.05 |
| Mar 31, 2020 | -80,935.53 |
| Mar 31, 2020 | -80,935.53 |
| Mar 31, 2019 | 1.54 Mn |
| Mar 31, 2019 | 1.54 Mn |